DeepHealth, a leader in AI-driven health informatics and a subsidiary of RadNet, Inc., is unveiling its advanced AI-powered radiology tools at the European Congress of Radiology (ECR) 2025 in Vienna. The company aims to address key clinical and operational challenges faced by healthcare providers through its innovative solutions, which are powered by DeepHealth OS— a secure, scalable, cloud-native platform that ensures interoperability across healthcare IT systems.
“At DeepHealth, we are leveraging AI to develop solutions that meet real-world clinical needs,” said Kees Wesdorp, PhD, President and CEO of RadNet’s Digital Health division. He added, “AI adoption in radiology can only succeed when AI is integrated into clinical workflows, empowering radiologists and care teams who currently rely on disconnected devices and data sources.”
AI Innovations to Enhance Radiology Workflows
DeepHealth’s latest AI tools are designed to streamline operations, improve diagnosis speed and accuracy, and support higher patient volumes. At ECR 2025, the company will showcase the Diagnostic Suite™, a cloud-native system that redefines medical imaging technology. The Diagnostic Suite integrates AI-powered interpretation with existing systems like RIS/PACS, offering advanced features for radiologists. It combines worklists, patient data, reporting, and high-speed viewers with AI and advanced visualization, offering a unified and scalable solution for practices of all sizes.
DeepHealth is also announcing updates to its SmartMammo™ system, which is designed to optimize breast cancer screening. This update will enhance integration with 2D mammograms and improve workflow efficiency. SmartMammo™ uses AI to detect and localize lesions in dense breast tissue, increasing cancer detection rates by 21%. The updates include CE-marked 2D technology for primary readings and second-reader roles in mammography.
AI Solutions for Lung, Prostate, and Brain Health
DeepHealth will also highlight its AI-powered solutions for lung, prostate, and brain health. The company’s AI-driven Lung solution is already part of the NHS England’s Lung Cancer Screening Program, one of the world’s largest lung cancer screening efforts. AI helps detect lung cancer earlier, improving the treatability of detected cancers. The system automates lung nodule detection, reporting, and patient management, enabling radiologists to work faster and more accurately.
In prostate cancer, DeepHealth’s AI-powered solution supports high-volume screening, diagnosis, and biopsy planning. With AI assistance, diagnostic sensitivity has increased to 97%, compared to 92% without AI support. The solution also reduces MRI read time by 37%.
DeepHealth’s AI-driven portfolio is already impacting healthcare, with over 800 clinical sites and 3,000 radiologists using its tools to deliver better care.
DeepHealth’s solutions will be on display at Booth No. 507, X5, during ECR 2025 in Vienna.
Read more:
- 22 States File Lawsuit To Block Trump Administration’S NIH Funding Cuts
- MIT’s Groundbreaking Wearable Fiber Computer To Revolutionize Health Monitoring
- Lack Of Sleep Could Lead To Serious Health Issues And A Shorter Life, Experts Warn
